pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Sep 10·1 min read
save

ARPA-H launches ADVOCATE program to fund AI agents for health tech companies

Sep 10, 2026·read at Endpoints ↗Positive

ARPA-H, the federal agency that funds breakthrough health technologies, announced the start of a new initiative called ADVOCATE.

The program will award millions of dollars in grants to health-technology companies that are building artificial-intelligence agents for clinical applications.

By supporting the development of AI tools, ADVOCATE aims to speed the translation of innovative algorithms into usable solutions that can improve patient care and streamline research.

The agency said the funding will be competitive and focused on projects that demonstrate clear clinical impact and scalability.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “The blueprint for clinical AI”

read at Endpoints ↗
73 words · retrieved Sep 10
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5h agoMerck reports mixed data for Lucentis competitor in diabetic macular edemaEndpoints
  • 7h agoAsahi Kasei lands approval for new HSV treatmentEndpoints
  • 9h agoMirum succeeds in rare liver disease trial; First Tracks delivers in celiacEndpoints
  • 9h agoBristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugsEndpoints
  • 9h agoBrent Saunders out as Bausch + Lomb CEO, an abrupt end to three-year runEndpoints